News
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
FDA grants orphan drug designation to HLX22 for gastric cancer, with a phase 2 trial showing improved progression-free ...
TG Therapeutics (TGTX) announced the publication of two journal articles one describing the evolution of CD20 treatments for multiple sclerosis ...
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results